Abbott (ABT) Tops Q4 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- S&P 500, Nasdaq hit record highs as Treasury yields stall, oil slips
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
- HubSpot to cut 7% of workforce in restructuring plan
- Paramount Skydance to close WBD deal, change ticker to SKYD
- Citi cuts investment banking analyst program to two years - Bloomberg
- Emera and Canadian Utilities agree to merge in $72B all-share deal
- Nasdaq notches record high close as investors focus on earnings
BofA/Merrill Lynch Upgrades Abbott Labs (ABT) to Buy
January 30, 2015 6:58 AM ESTBofA/Merrill Lynch upgraded Abbott Labs (NYSE: ABT) from Neutral to Buy with a price target of $52.00 (from $50.00).
Analyst Bob Hopkins cited three things, including: 1) ABT's strong Q4 results yesterday, which suggest estimates have bottomed with strong revenue growth and margin expansion highly likely... More



